Protagonist Therapeutics Inc buy Barclays PLC
Start price
17.09.25
/
50%
€53.00
Target price
17.09.26
€60.73
Performance (%)
32.08%
Price
13.01.26
€70.00
Summary
This prediction is currently active. With a performance of 32.08% the BUY prediction by Barclays_PLC is a big success. This prediction currently runs until 17.09.26. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Protagonist Therapeutics Inc | -0.709% | -0.709% |
| iShares Core DAX® | 1.644% | 4.865% |
| iShares Nasdaq 100 | 0.747% | 2.923% |
| iShares Nikkei 225® | 2.442% | 6.212% |
| iShares S&P 500 | 0.618% | 2.843% |
Comments by Barclays_PLC for this prediction
In the thread Protagonist Therapeutics Inc diskutieren
Protagonist Therapeutics (NASDAQ:PTGX) is now covered by analysts at Barclays PLC. They set an "overweight" rating and a $72.00 price target on the stock.
Ratings data for PTGX provided by MarketBeat
Stopped prediction by Barclays_PLC for Protagonist Therapeutics Inc
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€69.00
07.11.25
07.11.25
€76.27
07.11.26
07.11.26
1.45%
13.01.26
13.01.26
